Dental follicle mesenchymal stem cell administration ameliorates muscle weakness in MuSK-immunized mice

Ulusoy C., Zibandeh N., Yildirim S., Trakas N., Zisimopoulou P., Kucukerden M., ...Daha Fazla

JOURNAL OF NEUROINFLAMMATION, cilt.12, 2015 (SCI İndekslerine Giren Dergi) identifier identifier identifier


Background: Myasthenia gravis (MG) is an antibody-mediated autoimmune disease of the neuromuscular junction (NMJ), mostly associated with acetylcholine receptor (AChR) antibodies. Around 5-10 % of MG patients show antibodies to muscle-specific tyrosine kinase (MuSK). Mesenchymal stem cell (MSC) administration has been shown to ameliorate muscle weakness in the experimental autoimmune myasthenia gravis (EAMG) model induced by AChR immunization.